Skip to main content

Table 2 Clinicopathological features of 19 CC samples used for microarray analysis.

From: Genome-wide expression patterns associated with oncogenesis and sarcomatous transdifferentation of cholangiocarcinoma

Sample No Age/Sex Loca tion Size (cm) T N M Stage Gross appearance Differentiation Sub-class Comment
1 (CC-GHS) 68/F L 8.7 × 5.4 3 1 0 IVA MF PD A  
2 (CC-CYS) 57/M L NA 3 1 0 IVA MF +PDI MD A  
3 (CC-LJS) 42/M A NA 1 0 0 I ID WD B Intraductal papillary
4 (CC-BJP) 62/M P 7.8 × 5.6 1 0 0 I ID WD B Intraductal papillary
5 (CC-HSR) 66/M AP 7.3 × 6 2 0 0 II MF MD B  
6 (CC-HSW) 59/M AP 9 × 6.8 2 0 0 II MF MD B  
7 (CC-CSB) 60/M L 4 × 4.5 3 0 0 III MF MD B  
8 (CC-SJS) 71/M A 2.1 × 1.9 1 0 0 II MF WD B  
9 (CC-HDS) 63/M CBD 1.1 × 0.9 1 1 1 IVB ID MD B  
10 (CC-KHC) 47/M L 14 × 10 4 0 0 IVA MF PD C  
11 (CC-LHG) 42/M L 5.6 × 3.9 3 1 0 IVA MF PD C Combined with HCC
12 (CC-LSH) 40/F P 8.6 × 4 2 0 1 IVB MF PD C Combined with HCC
13 (CC-KHS) 70/F L 8.5 × 4.8 3 0 1 IVB MF +PDI PD C Combined with HCC
14 (CC-LMS) 38/F AP 5 × 3.7 4 0 1 IVB MF PD C Combined with HCC
15 (CC-KJA) 39/F LP 6 × 5 4 0 0 IVA MF MD C Combined with HCC
16 (CC-JSJ) 64/M L 0.5 × 0.5 2 0 1 IVB ID PD C  
17 (CC-YCU) 53/M L 4.3 × 2.1 3 1 0 IVA MF MD C  
18 (CC-GMG) 50/M L 7 × 3.5 2 0 0 II MF MD C  
19 (CC-BSD) 67/M L 2.9 × 2.7 4 0 0 IVA MF+P야 PD C  
  1. HCC, hepatocellular carcinoma; M, male; F, female; A, anterior segment; P, posterior segment; Med, medial segment; L, lateral segment; MF, mass forming type; PDI, periductal infiltrating type; IDG, intraductal growth type; WD, well differentiated; MD, moderately differentiated; PD, poorly differentiated; NA, not available.
  2. *International Hepato-Pancreato-Biliary Association classification.